MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-05-2026
Bioventus Total Inventories 2011-2026 | BVS
Annual Total Inventories Bioventus
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.2 M | 92.5 M | 91.3 M | 84.8 M | 61.7 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92.5 M | 61.7 M | 82.5 M |
Quarterly Total Inventories Bioventus
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.3 M | 96.5 M | 94 M | 90 M | 87.6 M | 97 M | 97.6 M | 96.3 M | 88 M | 84.8 M | 77 M | 69.1 M | 64.7 M | 61.7 M | 36.6 M | 34 M | 39.8 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 97.6 M | 29.1 M | 68 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
830 M | $ 110.24 | -2.86 % | $ 33.5 B |  USA |
 |
Waters Corporation
WAT
|
572 M | $ 289.16 | -3.79 % | $ 17.2 B | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 16.36 | -11.57 % | $ 176 M |  China |
 |
Sotera Health Company
SHC
|
54.4 M | $ 13.13 | -3.03 % | $ 3.73 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 102.08 | -0.97 % | $ 8.42 B |  Irlanda |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
BioNano Genomics
BNGO
|
7.83 M | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
629 M | $ 62.25 | -5.81 % | $ 24.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 23.53 | -4.74 % | $ 654 M | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 159.16 | -3.62 % | $ 7.89 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 195.51 | -1.33 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
297 K | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
3.65 M | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
379 M | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
1.21 M | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
191 M | $ 8.7 | -4.92 % | $ 1.89 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 264.2 | -1.56 % | $ 22 B | USA |
 |
Precipio
PRPO
|
384 K | $ 25.97 | -4.52 % | $ 33.7 M | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 16.78 | -3.95 % | $ 894 M | USA |
 |
Quotient Limited
QTNT
|
22 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Co-Diagnostics
CODX
|
1.66 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Meridian Bioscience
VIVO
|
67.8 M | - | - | $ 1.49 B | USA |
 |
Danaher Corporation
DHR
|
2.49 B | $ 181.52 | -3.27 % | $ 129 B | USA |